CEL-SCI and Advaxis among healthcare gainers; Puma Biotechnology leads the losers

|About: Advaxis, Inc. (ADXS)|By:, SA News Editor

Gainers: Pulmatrix (NASDAQ:PULM) +115%. Advaxis (NASDAQ:ADXS) +25%. CEL-SCI (NYSEMKT:CVM+22%. PhaseBio Pharmaceuticals (NASDAQ:PHAS) +21%. TG Therapeutics (NASDAQ:TGTX) +12%.

Losers: Puma Biotechnology (NASDAQ:PBYI) -9%. Seelos Therapeutics (NASDAQ:SEEL) -8%. Inspire Medical Systems (NYSE:INSP) -7%. Axsome Therapeutics (NASDAQ:AXSM) -7%. NovaBay Pharmaceuticals (NYSEMKT:NBY-5%.

Subscribe for full text news in your inbox